OR WAIT null SECS
The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.
Consolidation in the contract manufacturing landscape in recent years has resulted in service providers that now have varied scientific, technical, and technology expertise. The ability to provide real-time data analytics is in high demand, and there is a need for innovative flow filtration technologies, factors that seem to be driving some of this consolidation.
Feliza Mirasol is the science editor for BioPharm International.
eBook: Partnerships for Outsourcing, May 2021
When referring to this article, please cite it as F. Mirasol, “CDMO Landscape Seeing Changes as Consolidation Continues," BioPharm International Partnerships for Outsourcing eBook (May 2021).